Serum Institute inks deal to produce US-based biotech firm Novavax’s Covid vaccine
Posted by
www.biotecnika.org
The Serum Institute of India (SII) will buy the vaccine components
from Novavax and the two companies will equally split the revenue from
the sale of the product, net of agreed costs, Novavax said in a US
regulatory filing on Wednesday.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/serum-institute-inks-deal-to-produce-us-based-biotech-firm-novavaxs-covid-vaccine/articleshow/77401690.cms
Subscribe to:
Post Comments (Atom)
Post a Comment